tm logo
LUMYKRAS
REGISTERED

on 29 Mar 2023

Last Applicant/ Owned by

AMGEN INC.

One Amgen Center DriveThousand Oaks, CA 91320-1799

US

Serial Number

2097335 filed on 06th Apr 2021

Registration Number

TMA1173674 registered on 29th Mar 2023

Registration expiry Date

29th Mar 2033

Correspondent Address

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

LUMYKRAS

Trademark usage description

pharmaceutical preparations for use in the prevention of amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune disease Read More

Classification Information


Class [005]
Pharmaceutical preparations for use in the prevention of amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, oncology, tumors, solid and hematological tumors and growths, hematological and hemolytic diseases and disorders, including bone, joint, vertebral column, intestine, colon, skin, lung, eye, breast, ovary, cervix, stomach, bladder, kidney, head, brain, neck, and blood diseases and disorders; pharmaceutical preparations for use in the treatment of amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders; pharmaceutical preparations for use in the treatment of solid tumors and growths, hemolytic diseases and disorders, amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders


Classification kind code

11

Mark Details


Serial Number

2097335

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 190
on 29th Mar 2023
Registration Pending
Submitted for opposition 55
on 29th Mar 2023
Registered
Submitted for opposition 42
on 11th Jan 2023
Advertised
Submitted for opposition 27
on 16th Dec 2022
Approval Notice Sent
Submitted for opposition 26
on 16th Dec 2022
Approved
Submitted for opposition 22
on 12th Dec 2022
Search Recorded
Submitted for opposition 287
on 30th Jun 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 06th Apr 2021
Filed
Submitted for opposition 1
on 06th Apr 2021
Created
Submitted for opposition 31
on 06th Apr 2021
Formalized